Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesManagement of the antiphospholipid syndrome: new approaches
International Journal of Clinical Rheumatology, 10/19/09
Seif AM et al. – The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous) and pregnancy loss, among other clinical manifestations. These new treatments – potentially more effective and with fewer side effects – might be used in the future to treat clinical manifestations of this disease that are associated with devastating consequences, and are pending adequate clinical trials.
Related Articles
Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09
Relevance Score: 70%
The Cardiac Manifestations of Antiphospholipid Syndrome and Their Echocardiographic Recognition
Journal of The American Society of Echocardiography, 10/09/09
Relevance Score: 69%
Catastrophic antiphospholipid syndrome in a patient with Down syndrome
Lupus, 10/05/09
Relevance Score: 68%
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study
The Lancet Neurology, 10/16/09
Relevance Score: 66%
Right atrium myxoma coexisting with antiphospholipid syndrome
Cardiovascular Ultrasound, 10/12/09
Relevance Score: 66%
Today in Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study
European Heart Journal, 12/18/09
A clinical picture of chronic polyarticular tophaceous gout
Rheumatology International, 12/18/09
The diagnostic utilities of anti-agalactosyl IgG antibodies, anti-cyclic citrullinated peptide antibodies, and rheumatoid factors in rheumatoid arthritis
Rheumatology International, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor